Adlai Nortye Ltd. half-year net loss narrows 33.6% to USD 18.3 million

Reuters2025-12-29
<a href="https://laohu8.com/S/ALN">Adlai Nortye Ltd.</a> half-year net loss narrows 33.6% to USD 18.3 million

Adlai Nortye Ltd. $(ANL)$, a global clinical-stage oncology company, reported its unaudited financial results for the six months ended June 30, 2025. The company recorded no revenue for the period. Other operating income totaled USD 0.1 million. Administrative expenses amounted to USD 4.1 million. Research and development expenses reached USD 15.2 million. Total operating loss stood at USD 19.2 million. Other gains were USD 1.5 million, while investment income was USD 0.1 million. The company reported a net loss of USD 18.3 million for the period.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adlai Nortye Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-125572), on December 29, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment